OCEA — Ocean Biomedical Share News
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
Brief: Ocean Biomedical Announces Breakthrough Findings In EGFR-Mutant Lung Cancer
Brief: Ocean Biomedical Announces Receipt Of Notice From Nasdaq Regarding Late Filing Of Quarterly Report On Form 10-Q
Brief: Ocean Biomedical receives Nasdaq staff determination letter
Brief: Ocean Biomedical- Ratified Fully Countersigned Copy Of Revised Agreement With Virion Therapeutics Received On Sept 26
Brief: Ocean Biomedical Announces Receipt Of Notice From Nasdaq Regarding Late Filing Of Quarterly Report
Brief: Ocean Biomedical, Inc. Announces Receipt Of Notice From Nasdaq Regarding Late Filing Of Quarterly Report On Form 10-Q
Brief: Ocean Biomedical Announces Patent Allowance for Malaria Antibodies That Have Potential Capability to Protect Against Infection and Treat Severe Disease
Brief: Ocean Biomedical Announces Receipt Of Notice From Nasdaq
Ocean Biomedical Inc reports results for the quarter ended in September - Earnings Summary
Ocean Biomedical Inc expected to post a loss of 15 cents a share - Earnings Preview
Ocean Biomedical Inc expected to post a loss of 15 cents a share - Earnings Preview
Ocean Biomedical Inc expected to post a loss of 15 cents a share - Earnings Preview
Ocean Biomedical Inc expected to post a loss of 15 cents a share - Earnings Preview
Brief: Ocean Biomedical Inc - On March 1 Appointment Of Jolie Kahn, As Chief Financial Officer Of Ocean Biomedical Was Confirmed
Ocean Biomedical Inc expected to post a loss of 15 cents a share - Earnings Preview
Ocean Biomedical Inc expected to post a loss of 15 cents a share - Earnings Preview
Ocean Biomedical Inc expected to post a loss of 15 cents a share - Earnings Preview
Ocean Biomedical Inc expected to post a loss of 15 cents a share - Earnings Preview
Brief: Ocean Biomedical Says Co Received Notification Letter For Non-Compliance From Nasdaq